$ATRS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ANTARES PHARMA, INC.. Get notifications about new insider transactions in ANTARES PHARMA, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2007 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.65 | 30,000 | 49,500 | 30,000 | |
May 14 2007 | ATRS | ANTARES PHARMA, IN ... | STOVER JACK E | President and CEO | Option Exercise | A | 1.65 | 100,000 | 165,000 | 100,000 | |
May 14 2007 | ATRS | ANTARES PHARMA, IN ... | CARRARA DARIO | Senior Vice Preside ... | Option Exercise | A | 1.65 | 40,000 | 66,000 | 40,000 | |
May 14 2007 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.65 | 61,870 | 102,086 | 61,870 | |
Jan 18 2007 | ATRS | ANTARES PHARMA, IN ... | CARRARA DARIO | Senior Vice Preside ... | Option Exercise | A | 1.23 | 60,000 | 73,800 | 60,000 | |
Jan 18 2007 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Senior VP and CFO | Option Exercise | A | 1.23 | 60,000 | 73,800 | 60,000 | |
Jan 18 2007 | ATRS | ANTARES PHARMA, IN ... | SADOWSKI PETER L | Vice President | Option Exercise | A | 1.23 | 60,000 | 73,800 | 60,000 | |
Jan 18 2007 | ATRS | ANTARES PHARMA, IN ... | STOVER JACK E | President/CEO | Option Exercise | A | 1.23 | 120,000 | 147,600 | 120,000 | |
Jan 18 2007 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 1.23 | 20,000 | 24,600 | 20,000 | |
Nov 03 2006 | ATRS | ANTARES PHARMA, IN ... | CARRARA DARIO | Senior Vice Preside ... | Option Exercise | A | 1.26 | 80,000 | 100,800 | 261,442 | |
May 25 2006 | ATRS | ANTARES PHARMA, IN ... | STOVER JACK E | President/CEO | Grant | A | 0.00 | 86,666 | 0 | 486,035 | 399.4 K to 486 K (+21.70 %) |
May 05 2006 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | Director | Option Exercise | A | 1.55 | 10,000 | 15,500 | 10,000 | |
May 05 2006 | ATRS | ANTARES PHARMA, IN ... | SHROTRIYA RAJESH C | Director | Option Exercise | A | 1.55 | 10,000 | 15,500 | 10,000 | |
May 05 2006 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.55 | 10,000 | 15,500 | 10,000 | |
May 05 2006 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.55 | 10,000 | 15,500 | 10,000 | |
May 05 2006 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.55 | 10,000 | 15,500 | 10,000 | |
Jan 30 2006 | ATRS | ANTARES PHARMA, IN ... | HATTERSLEY JAMES E | Vice President-Busi ... | Option Exercise | A | 1.51 | 90,000 | 135,900 | 16,250 | |
Jan 30 2006 | ATRS | ANTARES PHARMA, IN ... | SADOWSKI PETER L | VP-Device Group | Option Exercise | A | 1.51 | 50,000 | 75,500 | 243,865 | |
Jan 30 2006 | ATRS | ANTARES PHARMA, IN ... | STOVER JACK E | President/CEO | Option Exercise | A | 1.51 | 220,000 | 332,200 | 358,619 | |
Jan 30 2006 | ATRS | ANTARES PHARMA, IN ... | CARRARA DARIO | Managing Director-F ... | Option Exercise | A | 1.51 | 90,000 | 135,900 | 218,900 | |
Jan 05 2006 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | Director | Option Exercise | A | 1.54 | 20,000 | 30,800 | 27,500 | |
Jan 05 2006 | ATRS | ANTARES PHARMA, IN ... | SHROTRIYA RAJESH C | Director | Option Exercise | A | 1.54 | 20,000 | 30,800 | 39,500 | |
Jan 05 2006 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.54 | 20,000 | 30,800 | 62,583 | |
Jan 05 2006 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.54 | 20,000 | 30,800 | 69,083 | |
Jan 05 2006 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.54 | 20,000 | 30,800 | 4,283,476 | |
May 16 2005 | ATRS | ANTARES PHARMA, IN ... | CHRISTIAN LAWRENCE M | CFO | Grant | A | 0.79 | 1,000 | 790 | 244,744 | 243.7 K to 244.7 K (+0.41 %) |
Apr 01 2005 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Grant | A | 1.06 | 33,700 | 35,722 | 13,648,760 | 13.6 M to 13.6 M (+0.25 %) |
Mar 31 2005 | ATRS | ANTARES PHARMA, IN ... | STOVER JACK E | President/CEO | Grant | A | 0.98 | 5,000 | 4,900 | 255,572 | 250.6 K to 255.6 K (+2.00 %) |
Mar 31 2005 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Grant | A | 0.98 | 65,000 | 63,700 | 13,615,060 | 13.6 M to 13.6 M (+0.48 %) |
Mar 29 2005 | ATRS | ANTARES PHARMA, IN ... | CHRISTIAN LAWRENCE M | CFO | Grant | A | 0.94 | 1,000 | 940 | 243,744 | 242.7 K to 243.7 K (+0.41 %) |
Mar 29 2005 | ATRS | ANTARES PHARMA, IN ... | CHRISTIAN LAWRENCE M | CFO | Grant | A | 0.94 | 1,000 | 940 | 243,744 | 242.7 K to 243.7 K (+0.41 %) |
Jan 25 2005 | ATRS | ANTARES PHARMA, IN ... | STOVER JACK E | President/CEO | Option Exercise | A | 1.21 | 40,000 | 48,400 | 0 | |
Jan 04 2005 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 2,500 | |
Jan 04 2005 | ATRS | ANTARES PHARMA, IN ... | SHROTRIYA RAJESH C | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 6,875 | |
Jan 04 2005 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 34,021 | |
Jan 04 2005 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 4,254,916 | |
Jan 04 2005 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 37,521 | |
Jan 04 2005 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 61,521 | |
Jan 03 2005 | ATRS | ANTARES PHARMA, IN ... | SADOWSKI PETER L | VP-Device Group | Option Exercise | A | 1.32 | 60,500 | 79,860 | 184,173 | |
Jan 03 2005 | ATRS | ANTARES PHARMA, IN ... | CARRARA DARIO | Managing Director-F ... | Option Exercise | A | 1.32 | 80,000 | 105,600 | 151,200 | |
Jan 03 2005 | ATRS | ANTARES PHARMA, IN ... | CHRISTIAN LAWRENCE M | CFO | Option Exercise | A | 1.32 | 27,500 | 36,300 | 240,544 | |
Jan 03 2005 | ATRS | ANTARES PHARMA, IN ... | STOVER JACK E | President/CEO | Option Exercise | A | 1.32 | 52,000 | 68,640 | 140,000 | |
Oct 25 2004 | ATRS | ANTARES PHARMA, IN ... | Wotton Paul K | Director | Option Exercise | A | 1.40 | 5,000 | 7,000 | 0 | |
Oct 25 2004 | ATRS | ANTARES PHARMA, IN ... | SHROTRIYA RAJESH C | Director | Option Exercise | A | 1.40 | 5,000 | 7,000 | 0 | |
Oct 25 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.40 | 1,250 | 1,750 | 14,583 | |
Oct 25 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.40 | 1,250 | 1,750 | 13,515,997 | |
Oct 25 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.40 | 1,250 | 1,750 | 56,083 | |
Oct 25 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 1.40 | 1,250 | 1,750 | 69,083 | |
Aug 31 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.23 | 80,000 | 98,400 | 13,515,497 | 13.4 M to 13.5 M (+0.60 %) |
Aug 30 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.18 | 11,000 | 12,980 | 12,935,497 | 12.9 M to 12.9 M (+0.09 %) |
Aug 27 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.00 | 125,000 | 125,000 | 12,924,497 | 12.8 M to 12.9 M (+0.98 %) |
Aug 26 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.01 | 100,000 | 101,000 | 12,799,497 | 12.7 M to 12.8 M (+0.79 %) |
Aug 25 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.06 | 125,000 | 132,500 | 10,299,497 | 10.2 M to 10.3 M (+1.23 %) |
Aug 24 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | P | 1.07 | 100,000 | 107,000 | 12,587,497 | 12.5 M to 12.6 M (+0.80 %) |
Aug 20 2004 | ATRS | ANTARES PHARMA, IN ... | CHRISTIAN LAWRENCE M | CFO | Buy | P | 1.04 | 1,000 | 1,040 | 81,627 | 80.6 K to 81.6 K (+1.24 %) |
Jul 26 2004 | ATRS | ANTARES PHARMA, IN ... | STOVER JACK E | President/COO | Option Exercise | A | 0.70 | 500,000 | 350,000 | 510,000 | |
Jul 26 2004 | ATRS | ANTARES PHARMA, IN ... | STOVER JACK E | President/COO | Grant | A | 0.00 | 100,000 | 0 | 130,000 | 30 K to 130 K (+333.33 %) |
Jul 23 2004 | ATRS | ANTARES PHARMA, IN ... | SHROTRIYA RAJESH C | Director | Option Exercise | A | 0.70 | 11,250 | 7,875 | 0 | |
Jul 23 2004 | ATRS | ANTARES PHARMA, IN ... | SHROTRIYA RAJESH C | Director | Option Exercise | A | 0.70 | 1,250 | 875 | 0 | |
Jul 23 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 0.70 | 1,250 | 875 | 0 | |
Jul 23 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 0.70 | 1,250 | 875 | 25,000 | |
Jul 23 2004 | ATRS | ANTARES PHARMA, IN ... | DRO PHILLIPPE | Director | Option Exercise | A | 0.70 | 1,250 | 875 | 52,500 | |
Jul 23 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 0.70 | 12,500 | 8,750 | 0 | |
Jul 23 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 0.70 | 1,250 | 875 | 25,000 | |
Jun 23 2004 | ATRS | ANTARES PHARMA, IN ... | SHROTRIYA RAJESH C | Director | Option Exercise | A | 0.90 | 500 | 450 | 0 | |
Jun 23 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 0.90 | 1,000 | 900 | 0 | |
Jun 23 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 0.90 | 2,000 | 1,800 | 0 | |
Jun 23 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 0.90 | 2,000 | 1,800 | 0 | |
Jun 23 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 0.90 | 1,000 | 900 | 25,000 | |
Jun 23 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 0.90 | 2,000 | 1,800 | 25,000 | |
Jun 23 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 0.90 | 2,000 | 1,800 | 25,000 | |
May 28 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Grant | A | 0.96 | 100,000 | 96,000 | 12,942,497 | 12.8 M to 12.9 M (+0.78 %) |
May 25 2004 | ATRS | ANTARES PHARMA, IN ... | SHROTRIYA RAJESH C | Director | Option Exercise | A | 0.95 | 500 | 475 | 0 | |
May 25 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 0.95 | 500 | 475 | 0 | |
May 25 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 0.95 | 500 | 475 | 25,000 | |
May 25 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 0.95 | 500 | 475 | 0 | |
May 25 2004 | ATRS | ANTARES PHARMA, IN ... | DRO PHILLIPPE | Director | Option Exercise | A | 0.95 | 500 | 475 | 52,500 | |
May 25 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 0.95 | 2,058,082 | 1,955,178 | 268,161 | 2.3 M to 268.2 K (-88.47 %) |
May 20 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 0.83 | 150,000 | 124,500 | 2,326,243 | 2.5 M to 2.3 M (-6.06 %) |
May 19 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 0.94 | 12,500 | 11,750 | 2,476,243 | 2.5 M to 2.5 M (-0.50 %) |
May 18 2004 | ATRS | ANTARES PHARMA, IN ... | CHRISTIAN LAWRENCE M | CFO | Buy | P | 0.94 | 3,000 | 2,820 | 80,627 | 77.6 K to 80.6 K (+3.86 %) |
May 18 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 0.96 | 500 | 480 | 0 | |
May 18 2004 | ATRS | ANTARES PHARMA, IN ... | DRO PHILLIPPE | Director | Option Exercise | A | 0.96 | 500 | 480 | 52,500 | |
May 17 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.00 | 492,500 | 492,500 | 2,488,743 | 3 M to 2.5 M (-16.52 %) |
May 17 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.00 | 50,000 | 50,000 | 2,981,243 | 3 M to 3 M (-1.65 %) |
May 13 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.00 | 210,000 | 210,000 | 3,031,243 | 3.2 M to 3 M (-6.48 %) |
May 12 2004 | ATRS | ANTARES PHARMA, IN ... | SHROTRIYA RAJESH C | Director | Option Exercise | A | 1.01 | 500 | 505 | 0 | |
May 12 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.01 | 2,000 | 2,020 | 0 | |
May 12 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.01 | 2,000 | 2,020 | 0 | |
May 12 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 1.01 | 2,000 | 2,024 | 25,000 | |
May 12 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.01 | 2,000 | 2,020 | 25,000 | |
Apr 20 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.32 | 500 | 660 | 0 | |
Apr 20 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.32 | 500 | 660 | 0 | |
Apr 20 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.32 | 500 | 660 | 0 | |
Apr 20 2004 | ATRS | ANTARES PHARMA, IN ... | DRO PHILLIPPE | Director | Option Exercise | A | 1.32 | 500 | 660 | 52,500 | |
Apr 20 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 1.32 | 500 | 660 | 25,000 | |
Apr 20 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 1.32 | 500 | 660 | 25,000 | |
Apr 20 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.32 | 500 | 660 | 25,000 | |
Apr 07 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.40 | 2,000 | 2,800 | 57,000 | |
Apr 07 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 1.40 | 2,000 | 2,800 | 63,583 | |
Apr 07 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.40 | 2,000 | 2,800 | 50,333 | |
Apr 07 2004 | ATRS | ANTARES PHARMA, IN ... | DRO PHILLIPPE | Director | Option Exercise | A | 1.40 | 2,000 | 2,800 | 54,500 | |
Apr 07 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.40 | 2,000 | 2,800 | 35,083 | |
Mar 30 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.45 | 500 | 725 | 48,333 | |
Mar 30 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.45 | 500 | 725 | 48,333 | |
Mar 30 2004 | ATRS | ANTARES PHARMA, IN ... | DRO PHILLIPPE | Director | Option Exercise | A | 1.45 | 500 | 725 | 52,500 | |
Mar 30 2004 | ATRS | ANTARES PHARMA, IN ... | DRO PHILLIPPE | Director | Option Exercise | A | 1.45 | 500 | 725 | 52,500 | |
Mar 19 2004 | ATRS | ANTARES PHARMA, IN ... | DRO PHILLIPPE | Director | Option Exercise | A | 1.33 | 1,000 | 1,330 | 76,000 | |
Mar 19 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 1.33 | 1,000 | 1,330 | 61,583 | |
Mar 19 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 1.33 | 1,000 | 1,330 | 61,583 | |
Mar 19 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.33 | 1,000 | 1,330 | 37,583 | |
Mar 19 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.33 | 1,000 | 1,330 | 37,583 | |
Mar 10 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.25 | 8,333 | 10,416 | 33,083 | |
Mar 10 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Grant | A | 1.00 | 25,000 | 25,000 | 40,000 | 15 K to 40 K (+166.67 %) |
Mar 03 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Option Exercise | X | 0.28 | 2,250,000 | 630,000 | 0 | |
Mar 03 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Buy | X | 0.28 | 2,250,000 | 630,000 | 3,241,243 | 991.2 K to 3.2 M (+226.99 %) |
Mar 02 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.25 | 8,333 | 10,416 | 8,333 | |
Mar 02 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Grant | A | 1.00 | 25,000 | 25,000 | 40,000 | 15 K to 40 K (+166.67 %) |
Mar 02 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 1.25 | 8,333 | 10,416 | 8,333 | |
Mar 02 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Grant | A | 1.00 | 25,000 | 25,000 | 27,000 | 2 K to 27 K (+1,250.00 %) |
Mar 02 2004 | ATRS | ANTARES PHARMA, IN ... | CHRISTIAN LAWRENCE M | CFO | Option Exercise | A | 1.25 | 16,667 | 20,834 | 16,667 | |
Mar 02 2004 | ATRS | ANTARES PHARMA, IN ... | CHRISTIAN LAWRENCE M | CFO | Buy | P | 1.00 | 25,000 | 25,000 | 77,627 | 52.6 K to 77.6 K (+47.50 %) |
Mar 02 2004 | ATRS | ANTARES PHARMA, IN ... | CHRISTIAN LAWRENCE M | CFO | Option Exercise | A | 1.25 | 16,667 | 20,834 | 16,667 | |
Mar 02 2004 | ATRS | ANTARES PHARMA, IN ... | CHRISTIAN LAWRENCE M | CFO | Buy | P | 1.00 | 25,000 | 25,000 | 77,627 | 52.6 K to 77.6 K (+47.50 %) |
Feb 17 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.08 | 2,000 | 2,160 | 24,750 | |
Feb 17 2004 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 1.08 | 2,000 | 2,160 | 24,750 | |
Mar 02 2004 | ATRS | ANTARES PHARMA, IN ... | CHRISTIAN LAWRENCE M | CFO | Buy | P | 1.00 | 25,000 | 25,000 | 77,627 | 52.6 K to 77.6 K (+47.50 %) |
Feb 17 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.08 | 2,000 | 2,160 | 55,000 | |
Feb 17 2004 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 1.08 | 2,000 | 2,160 | 55,000 | |
Feb 17 2004 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 1.08 | 2,000 | 2,160 | 28,250 | |
Feb 17 2004 | ATRS | ANTARES PHARMA, IN ... | CLARK JAMES L | Director | Option Exercise | A | 1.08 | 2,000 | 2,160 | 52,250 | |
Feb 02 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.16 | 14,755 | 17,116 | 1,021,243 | 1 M to 1 M (-1.42 %) |
Feb 02 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.05 | 197,000 | 206,850 | 1,035,998 | 1.2 M to 1 M (-15.98 %) |
Feb 17 2004 | ATRS | ANTARES PHARMA, IN ... | DRO PHILLIPPE | Director | Option Exercise | A | 1.08 | 2,000 | 2,160 | 75,000 | |
Jan 26 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.08 | 7,000 | 7,560 | 1,232,998 | 1.2 M to 1.2 M (-0.56 %) |
Jan 22 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.06 | 25,000 | 26,500 | 1,239,998 | 1.3 M to 1.2 M (-1.98 %) |
Jan 15 2004 | ATRS | ANTARES PHARMA, IN ... | XMARK ASSET MANAGEMENT LLC | 10% Owner | Sell | S | 1.14 | 3,000 | 3,420 | 1,279,498 | 1.3 M to 1.3 M (-0.23 %) |